Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Kari Syrjänen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Papillomaviridae

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Cervix Uteri

Phenomena

Nucleic Acid Hybridization

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
122
Syrjänen, Stina
52
Lipponen, Pertti
31
Eskelinen, Matti
30
Aaltomaa, Sirpa
28
Mäntyjärvi, Rauno
27
Branca, Margherita
21
Tosi, Piero
20
Kosma, Veli-Matti
19
Ciotti, Marco
19
Favalli, Cartesio
19
Costa, Silvano
17
Santopietro, Rosa
17
Cintorino, Marcella
17
Benedetto, Arrigo
16
Paba, Pierpaolo

Sign-in to see all Coauthors

Publications

TOP 3
Syrjänen Kari; Shabalova Irena; Ivanchenko Olga; Kljukina Ludmila; Grunberga Valerija; Syrjänen Stina;
Reproducibility of classification and correction for verification bias as determinants of performance of Papanicolaou smear cytology in the screening setting: experience from the New Independent States of the former Soviet Union cohort study.
Latvala A; Syrjänen K; Salmenoja H; Salminen E
Anaemia and other predictors of fatigue among patients on palliative therapy for advanced cancer.
Syrjänen Kari; Shabalova Irena; Naud Paulo; Kozachenko Vladimir; Derchain Sophie; Zakharchenko Sergej; Roteli-Martins Cecilia; Nerovjna Raisa; Longatto-Filho Adhemar; Kljukina Ludmila; Tatti Silvio; Branovskaja Marina; Hammes Luciano Serpa; Branca Margherita; Grunjberga Valerija; Erzen Mojca; Sarian Luis Otavio; Juschenko Anna; Costa Silvano; Podistov Jurij; Syrjänen Stina;
Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Kari Syrjänen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Syrjänen Kari; Shabalova Irena; Ivanchenko Olga; Kljukina Ludmila; Grunberga Valerija; Syrjänen Stina;
Reproducibility of classification and correction for verification bias as determinants of performance of Papanicolaou smear cytology in the screening setting: experience from the New Independent States of the former Soviet Union cohort study.
Acta cytologica 2009;53(5):548-57.
2009: Latvala A; Syrjänen K; Salmenoja H; Salminen E
Anaemia and other predictors of fatigue among patients on palliative therapy for advanced cancer.
Anticancer research 2009;29(7):2569-75.
2009: Syrjänen Kari; Shabalova Irena; Naud Paulo; Kozachenko Vladimir; Derchain Sophie; Zakharchenko Sergej; Roteli-Martins Cecilia; Nerovjna Raisa; Longatto-Filho Adhemar; Kljukina Ludmila; Tatti Silvio; Branovskaja Marina; Hammes Luciano Serpa; Branca Margherita; Grunjberga Valerija; Erzen Mojca; Sarian Luis Otavio; Juschenko Anna; Costa Silvano; Podistov Jurij; Syrjänen Stina;
Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(5):934-42.
2009: Syrjänen Stina; Waterboer Tim; Sarkola Marja; Michael Kristina; Rintala Marjut; Syrjänen Kari; Grenman Seija; Pawlita Michael
Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy.
The Journal of general virology 2009;90(Pt 6):1515-26.
2009: Korkeila E; Talvinen K; Jaakkola P M; Minn H; Syrjänen K; Sundström J; Pyrhönen S
Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer.
British journal of cancer 2009;100(6):874-80.
2009: Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
Anticancer research 2009;29(1):99-106.
2009: Pitta Denise Rocha; Sarian Luis Otávio; Campos Elisabete Aparecida; Rabelo-Santos Sílvia Helena; Syrjänen Kari; Derchain Sophie Françoise
Phylogenetic classification of human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia in women from a densely populated Brazilian urban region.
São Paulo medical journal = Revista paulista de medicina 2009;127(3):122-7.
2009: Guarisi Renata; Sarian Luis Otavio; Hammes Luciano Serpa; Longatto-Filho Adhemar; Derchain Sophie F M; Roteli-Martins Cecília; Naud Paulo; Erzen Mojca; Branca Margherita; Tatti Sílvio; Costa Silvano; Syrjänen Stina; Bragança Joana F; Syrjänen Kari
Smoking worsens the prognosis of mild abnormalities in cervical cytology.
Acta obstetricia et gynecologica Scandinavica 2009;88(5):514-20.
2008: Elzagheid Adam; Korkeila Eija; Bendardaf Riyad; Buhmeida Abdelbaset; Heikkilä Suvi; Vaheri Antti; Syrjänen Kari; Pyrhönen Seppo; Carpén Olli
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
Human pathology 2008;39(12):1737-43.
2008: Bendardaf Riyad; Buhmeida Abdelbaset; Hilska Marja; Laato Matti; Syrjänen Stina; Syrjänen Kari; Collan Yrjö; Pyrhönen Seppo
VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
Anticancer research 2008;28(6B):3865-70.
2008: Bendardaf Riyad; Lamlum Hanan; Ristamäki Raija; Syrjänen Kari; Pyrhönen Seppo
Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.
Oncology reports 2008;20(5):999-1004.
2008: Vihinen Pia; Koskivuo Ilkka; Syrjänen Kari; Tervahartiala Taina; Sorsa Timo; Pyrhönen Seppo
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
Melanoma research 2008;18(4):268-73.
2008: Monsonego Joseph; Pollini Giuseppe; Evrard Marie José; Sednaoui Patrice; Monfort Laura; Quinzat Dominique; Dachez Roger; Syrjänen Kari
Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
International journal of STD & AIDS 2008;19(6):385-92.
2008: Monsonego Joseph; Pollini Giuseppe; Evrard Marie José; Sednaoui Patrice; Monfort Laura; Zerat Laurent; Syrjänen Kari
Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests.
Sexually transmitted diseases 2008;35(5):521-7.
2008: Syrjänen Stina; Syrjänen Kari
The history of papillomavirus research.
Central European journal of public health 2008;16 Suppl():S7-13.
2008: Syrjänen K; Naud P; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes L S; Matos J; Gontijo R; Sarian L; Bragança J; Arlindo F C; Maeda M Y S; Lörincz A; Dores G B; Costa S; Syrjänen S
Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort.
International journal of STD & AIDS 2008;19(4):251-8.
2008: Branca Margherita; Ciotti Marco; Giorgi Colomba; Santini Donatella; Di Bonito Luigi; Costa Silvano; Benedetto Arrigo; Bonifacio Donatella; Di Bonito Paola; Paba Pierluigi; Accardi Luisa; Syrjänen Stina; Favalli Cartesio; Syrjänen Kari;
Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2008;27(2):265-73.
2008: Giuliani Laura; Ronci Corrado; Bonifacio Daniela; Di Bonito Luigi; Favalli Cartesio; Perno Carlo Federico; Syrjänen Kari; Ciotti Marco
Detection of oncogenic DNA viruses in colorectal cancer.
Anticancer research 2008;28(2B):1405-10.
2008: Rama Cristina Helena; Roteli-Martins Cecilia Maria; Derchain Sophie Françoise Mauricette; Longatto-Filho Adhemar; Gontijo Renata Clementino; Sarian Luís Otávio Zanatta; Syrjänen Kari; Aldrighi José Mendes
[Prevalence of genital HPV infection among women screened for cervical cancer]
Revista de saúde pública 2008;42(1):123-30.
2008: Syrjänen Kari; Shabalova Irena; Petrovichev Nicolay; Kozachenko Vladimir; Zakharova Tatjana; Pajanidi Julia; Podistov Jurij; Chemeris Galina; Sozaeva Larisa; Lipova Elena; Tsidaeva Irena; Ivanchenko Olga; Pshepurko Alla; Zakharenko Sergej; Nerovjna Raisa; Kljukina Ludmila; Erokhina Oksana; Branovskaja Marina; Nikitina Maritta; Grunberga Valerija; Grunberg Alexandr; Juschenko Anna; Santopietro Rosa; Cintorino Marcella; Tosi Piero; Syrjänen Stina
Age at menarche is not an independent risk factor for high-risk human papillomavirus infections and cervical intraepithelial neoplasia.
International journal of STD & AIDS 2008;19(1):16-25.
2008: Paba Pierpaolo; Bonifacio Daniela; Di Bonito Luigi; Ombres Domenico; Favalli Cartesio; Syrjänen Kari; Ciotti Marco
Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways.
Intervirology 2008;51(4):230-4.
2008: Syrjänen K
New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
European journal of gynaecological oncology 2008;29(3):205-21.
2008: Syrjänen K; Kulmala S M; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunjberga V; Grunjberg A; Juschenko A; Santopietro R; Cintorino M; Tosi P; Syrjänen S
Epidemiological, clinical and viral determinants of the increased prevalence of high-risk human papillomavirus (HPV) infections in elderly women.
European journal of gynaecological oncology 2008;29(2):114-22.
2008: Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1046-53.
2007: Bendardaf Riyad; Buhmeida Abdelbaset; Ristamäki Raija; Syrjänen Kari; Pyrhönen Seppo
MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases.
Scandinavian journal of gastroenterology 2007;42(12):1473-8.
2007: Alderisio Mauro; Branca Margherita; Erzen Mojca; Longatto-Filho Adhemar; Derchain Sophie; Tatti Silvio; Vighi Susana; Roteli-Martins Cecilia; Leoncini Luciano; Maeda Marina Y S; Montis Douglas; Gontijo Renata; Sarian Luis Otavio; Syrjänen Kari
Interlaboratory quality control in gynecologic cytopathology using the novel CONQUISTADOR software. Interobserver reproducibility in the Latin American screening study.
Acta cytologica 2007;51(6):872-81.
2007: Bendardaf Riyad; Elzagheid Adam; Lamlum Hanan; Algars Annika; Korkeila Eija; Ristamäki Raija; Collan Yrjo; Syrjänen Kari; Pyrhönen Seppo
Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.
Scandinavian journal of gastroenterology 2007;42(4):471-6.
2007: Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
European journal of obstetrics, gynecology, and reproductive biology 2007;130(2):223-31.
2007: Syrjänen K
Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix.
European journal of gynaecological oncology 2007;28(5):337-51.
2007: Syrjänen Kari; Shabalova Irena; Petrovichev Nicolay; Kozachenko Vladimir; Zakharova Tatjana; Pajanidi Julia; Podistov Jurij; Chemeris Galina; Sozaeva Larisa; Lipova Elena; Tsidaeva Irena; Ivanchenko Olga; Pshepurko Alla; Zakharenko Sergej; Nerovjna Raisa; Kljukina Ludmila; Erokhina Oksana; Branovskaja Marina; Nikitina Maritta; Grunberga Valerija; Grunberg Alexandr; Juschenko Anna; Santopietro Rosa; Cintorino Marcella; Tosi Piero; Syrjänen Stina
Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN.
European journal of epidemiology 2007;22(10):723-35.
2007: Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(4):212-20.
2006: Syrjänen Kari; Shabalova Irena; Petrovichev Nicolay; Kozachenko Vladimir; Zakharova Tatjana; Pajanidi Julia; Podistov Jurij; Chemeris Galina; Sozaeva Larisa; Lipova Elena; Tsidaeva Irena; Ivanchenko Olga; Pshepurko Alla; Zakharenko Sergej; Nerovjna Raisa; Kljukina Ludmila; Erokhina Oksana; Branovskaja Marina; Nikitina Maritta; Grunberga Valerija; Grunberg Alexandr; Juschenko Anna; Santopietro Rosa; Cintorino Marcella; Tosi Piero; Syrjanen Stina
Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections.
Anticancer research 2006;26(6C):4729-40.
2006: Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen S; Favalli C; Syrjänen K
Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
Diagnostic cytopathology 2006;34(11):739-48.
2006: Branca Margherita; Giorgi Colomba; Ciotti Marco; Santini Donatella; Di Bonito Luigi; Costa Silvano; Benedetto Arrigo; Bonifacio Daniela; Di Bonito Paola; Paba Pierpaulo; Accardi Luisa; Mariani Luciano; Ruutu Merja; Syrjänen Stina M; Favalli Cartesio; Syrjänen K;
Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2006;25(4):383-92.
2006: Bendardaf R; Algars A; Elzagheid A; Korkeila E; Ristamäki R; Lamlum H; Collan Y; Syrjänen K; Pyrhönen S
Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.
Oncology reports 2006;16(4):741-6.
2006: Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Favalli C; Syrjänen K;
Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.
Journal of clinical pathology 2006;59(10):1044-51.
2006: Giuliani Laura; Coletti Anna; Syrjänen Kari; Favalli Cartesio; Ciotti Marco
Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping.
Anticancer research 2006;26(5B):3939-41.
2006: Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen S; Favalli C; Syrjänen K;
Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer.
Diagnostic cytopathology 2006;34(8):555-63.
2006: Santopietro Rosa; Shabalova Irena; Petrovichev Nicolay; Kozachenko Vladimir; Zakharova Tatjana; Pajanidi Julia; Podistov Jurij; Chemeris Galina; Sozaeva Larisa; Lipova Elena; Tsidaeva Irena; Ivanchenko Olga; Pshepurko Alla; Zakharenko Sergej; Nerovjna Raisa; Kljukina Ludmila; Erokhina Oksana; Branovskaja Marina; Nikitina Maritta; Grunberga Valerija; Grunberg Alexandr; Juschenko Anna; Cintorino Marcella; Tosi Piero; Syrjänen Kari; Syrjänen Stina
Cell cycle regulators p105, p107, Rb2/p130, E2F4, p21CIP1/WAF1, cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(7):1250-6.
2006: Ciotti Marco; Giuliani Laura; Ambrogi Vincenzo; Ronci Corrado; Benedetto Arrigo; Mineo Tommaso C; Syrjänen Kari; Favalli Cartesio
Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer.
Oncology reports 2006;16(1):183-9.
2006: Ruutu M; Wahlroos N; Syrjänen K; Johansson B; Syrjänen S
Effects of 17beta-estradiol and progesterone on transcription of human papillomavirus 16 E6/E7 oncogenes in CaSki and SiHa cell lines.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):1261-8.
2006: Longatto-Filho A; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain S F M; Hammes L; Sarian L O; Bragança J F; Matos J; Gontijo R; Lima T; Maeda M Y S; Tatti S; Syrjänen S; Dores G; Lörincz A; Syrjänen K
Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):955-62.
2006: Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.
Anticancer research 2006;26(2B):1543-56.
2006: Buhmeida Abdelbaset; Algars Annika; Ristamäki Raija; Collan Yrjö; Syrjänen Kari; Pyrhönen Seppo
Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.
Anticancer research 2006;26(1B):455-62.
2006: Branca Margherita; Giorgi Colomba; Ciotti Marco; Santini Donatella; Di Bonito Luigi; Costa Silvano; Benedetto Arrigo; Bonifacio Donatella; Di Bonito Paola; Paba Pierluigi; Accardi Luisa; Mariani Luciano; Syrjänen Stina; Favalli Cartesio; Syrjänen Kari;
Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer.
Acta cytologica 2006;50(1):6-15.
2006: Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Benedetto A; Paba P; Costa S; Bonifacio D; Di Bonito P; Accardi L; Favalli C; Syrjänen K;
Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
Journal of clinical pathology 2006;59(1):40-7.
2006: Naud P; Matos J; Hammes L; Stuckzynski J; Brouwers K; Magno V; Dias E; Crusius P; d'Avila A; Campos C; Costa M; Höblik M; Marc C; Marroni R; Syrjänen K
Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil.
European journal of obstetrics, gynecology, and reproductive biology 2006;124(1):110-8.
2006: Buhmeida A; Algars A; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.
Oncology 2006;70(6):427-37.
2006: Di Bonito Paola; Grasso Felicia; Mochi Stefania; Accardi Luisa; Donà Maria Gabriella; Branca Margherita; Costa Silvano; Mariani Luciano; Agarossi Alberto; Ciotti Marco; Syrjänen Kari; Giorgi Colomba
Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.
Infectious agents and cancer 2006;1():6.
2006: Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Syrjänen S; Favalli C; Syrjänen K;
Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer.
European journal of gynaecological oncology 2006;27(3):215-23.
2005: Nonogaki Suely; Wakamatsu Alda; Filho Adhemar Longatto; Roteli-Martins Cecília; di Loreto Celso; Maeda Marina Yoshiê Sakamoto; Utagawa Maria Lúcia; Pereira Sônia Maria Miranda; Polli Sabrina; Alves Venâncio A F; Syrjänen Kari
Molecular strategies for identifying human papillomavirus infection in routinely processed samples: focus on paraffin sections.
Journal of lower genital tract disease 2005;9(4):219-24.
2005: Longatto-Filho Adhemar; Maeda Marina Yoshiê Sakamoto; Erzen Mojca; Branca Margherita; Roteli-Martins Cecília; Naud Paulo; Derchain Sophie Françoise Mauricette; Hammes Luciano; Matos Jean; Gontijo Renata; Sarian Luis Otávio; Lima Temístocles P; Tatti Sílvio; Syrjänen Stina; Syrjänen Kari
Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
Acta cytologica 2005;49(5):500-6.
2005: Syrjänen K; Naud P; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes L S; Matos J; Gontijo R; Sarian L; Braganca J; Arlindo F C; Maeda M Y S; Lörincz A; Dores G B; Costa S; Syrjänen S
Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
Anticancer research 2005;25(5):3469-80.
2005: Branca Margherita; Morosini Pierluigi; Severi Pierluigi; Erzen Mojca; Di Benedetto Claudio; Syrjänen Kari
New statistical software for intralaboratory and interlaboratory quality control in clinical cytology. Validation in a simulation study on clinical samples.
Acta cytologica 2005;49(4):398-404.
2005: Buhmeida Abdelbaset; Ristamäki Raija; Lamlum Hanan; Bendardaf Riyad; Heikkilä Suvi; Collan Yrjö; Syrjänen Kari; Pyrhönen Seppo
Nuclear area is a prognostic determinant in advanced colorectal cancer.
Anticancer research 2005;25(4):3083-8.
2005: Branca Margherita; Giorgi Colomba; Santini Donatella; Di Bonito Luigi; Ciotti Marco; Costa Silvano; Benedetto Arrigo; Casolati Elena A; Favalli Cartesio; Paba Pierluigi; Di Bonito Paola; Mariani Luciano; Syrjänen Stina; Bonifacio Donatella; Accardi Luisa; Zanconati Francesca; Syrjänen Kari;
Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer.
American journal of clinical pathology 2005;124(1):113-21.
2005: Longatto Filho Adhemar; Utagawa Maria Lúcia; Shirata Neuza Kasumi; Pereira Sônia Maria Miranda; Namiyama Gislene M; Kanamura Cristina Takami; Santos Gilda da Cunha; de Oliveira Marilene Almeida; Wakamatsu Alda; Nonogaki Suely; Roteli-Martins Cecília; di Loreto Celso; Mattosinho de Castro Ferraz Maria da Gloria; Maeda Marina Yoshiê Sakamoto; Alves Venâncio A F; Syrjänen Kari
Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2005;24(2):118-24.
2005: Syrjänen S; Shabalova I; Petrovichev N; Podistov J; Ivanchenko O; Zakharenko S; Nerovjna R; Kljukina L; Branovskaja M; Juschenko A; Tosi P; Syrjänen K;
Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union.
International journal of STD & AIDS 2005;16(3):217-23.
2005: Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Cintorino M; Santopietro R; Tosi P; Syrjänen K
Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union.
European journal of gynaecological oncology 2005;26(5):491-8.
2005: Sarian L O; Derchain S F; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança J F; Lima T P; Maeda M Y S; Lörincz A; Dores G B; Costa S; Syrjänen S; Syrjänen K
Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Journal of medical screening 2005;12(3):142-9.
2004: Branca Margherita; Ciotti Marco; Santini Donatella; Bonito Luigi Di; Benedetto Arrigo; Giorgi Colomba; Paba Pierpaolo; Favalli Carterio; Costa Silvano; Agarossi Alberto; Alderisio Mauro; Syrjänen Kari;
Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.
American journal of clinical pathology 2004;122(6):902-11.
2004: Shirata Neuza Kasumi; Espoladore Luiz Marcelo Warneck; Filho Adhemar Longatto; Pittoli Janaína Erica; di Loreto Celso; Pereira Sonia Maria Miranda; Maeda Marina Yoshie Sakamoto; Utagawa Maria Lúcia; da Silva Aguiar Luciana; Roteli-Martins Cecília; Martinez Edson G; Syrjänen Kari
High-risk HPV detection by Hybrid Capture and ploidy determination by a computer-assisted system in cervical biopsies.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2004;26(5):295-300.
2004: Branca M; Ciotti M; Santini D; Di Bonito L; Giorgi C; Benedetto A; Paba P; Favalli C; Costa S; Agarossi A; Alderisio M; Syrjänen K
p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(4):354-65.
2004: Ruutu Merja; Johansson Bo; Grenman Reidar; Syrjänen Kari; Syrjänen Stina
Effect of confluence state and passaging on global cancer gene expression pattern in oral carcinoma cell lines.
Anticancer research 2004;24(5A):2627-31.
2004: Nonogaki Suely; Wakamatsu Alda; Longatto Filho Adhemar; Pereira Sonia Maria Miranda; Utagawa Maria Lúcia; Ferreira Alves Venâncio Avancini; Di Loreto Celso; Sakamoto Maeda Marina Yoshiê; Lima Temístocles P; Roteli-Martins Cecília; Syrjänen Kari
Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison.
Acta cytologica 2004;48(4):514-20.
2004: Kulmala S-M; Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Podistov J; Ivanchenko O; Zakharenko S; Nerovjna R; Kljukina L; Branovskaja M; Grunberga V; Juschenko A; Tosi P; Santopietro R; Syrjänen K
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools.
Journal of clinical microbiology 2004;42(6):2470-5.
2004: Syrjänen Stina; Shabalova Irena; Petrovichev Nicolay; Kozachenko Vladimir; Zakharova Tatjana; Pajanidi Julia; Podistov Jurij; Chemeris Galina; Sozaeva Larisa; Lipova Elena; Tsidaeva Irena; Ivanchenko Olga; Pshepurko Alla; Zakharenko Sergej; Nerovjna Raisa; Kljukina Ludmila; Erokhina Oksana; Branovskaja Marina; Nikitina Maritta; Grunberga Valerija; Grunberg Alexandr; Juschenko Anna; Tosi Piero; Cintorino Marcella; Santopietro Rosa; Syrjänen Kari
Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union.
Journal of clinical microbiology 2004;42(2):505-11.
2004: Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
European journal of gynaecological oncology 2004;25(6):689-98.
2004: Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
European journal of gynaecological oncology 2004;25(5):577-84.
2003: Syrjänen Stina; Shabalova Irena; Petrovichev Nicolaj; Kozachenko Vladimir; Zakharova Tatjana; Pajanidi Julia; Podistov Julia; Chemeris Galina; Sozaeva Larisa; Lipova Elena; Tsidaeva Irena; Ivanchenko Olga; Pshepurko Alla; Zakharenko Sergej; Nerovjna Raisa; Kljukina Ludmila; Erokhina Oksana; Branovskaja Marina; Nikitina Maritta; Grujnberga Valerija; Grujnberg Alexandr; Juschenko Anna; Johansson Bo; Tosi Piero; Cintorino Marcella; Santopietro Rosa; Syrjänen Kari
Sexual habits and human papillomavirus infection among females in three New Independent States of the former Soviet Union.
Sexually transmitted diseases 2003;30(9):680-4.
2003: Shirata Neuza Kasumi; Longatto Filho Adhemar; Roteli-Martins Cecília; Espoladore Luiz Marcelo W; Pittoli Janaína Erika; Syrjänen Kari
Applicability of liquid-based cytology to the assessment of DNA content in cervical lesions using static cytometry.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2003;25(4):210-4.
2003: Costa Silvano; De Simone Pia; Venturoli Simona; Cricca Monica; Zerbini Maria L; Musiani Monica; Terzano Patrizia; Santini Donatella; Cristiani Paolo; Syrjänen Stina; Syrjänen Kari
Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.
Gynecologic oncology 2003;90(2):358-65.
2003: Branca M; Garbuglia A R; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
International journal of STD & AIDS 2003;14(6):417-25.
2002: Erzen M; Mozina A; Bertole J; Syrjänen K
Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix.
European journal of obstetrics, gynecology, and reproductive biology 2002;101(2):185-91.
2001: Cintorino M; Tripod S A; Santopietro R; Antonio P; Lutfi A; Chang F; Syrjänen S; Shen Q; Tosi P; Syrjänen K
Cytokeratin expression patterns as an indicator of tumour progression in oesophageal squamous cell carcinoma.
Anticancer research 2001;21(6A):4195-201.
2001: Costa S; Terzano P; Santini D; Ceccarelli C; Martoni A; Angelelli B; Panetta A; Bovicelli A; Cristiani P; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
Neoadjuvant chemotherapy in cervical carcinoma: regulators of cell cycle, apoptosis, and proliferation as determinants of response to therapy and disease outcome.
American journal of clinical pathology 2001;116(5):729-37.
2001: Erzen M; Rakar S; Klancnik B; Syrjänen K;
Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
Gynecologic oncology 2001;83(1):100-8.
2001: Branca M; Rossi E; Alderisio M; Migliore G; Morosini P L; Vecchione A; Sopracordevole F; Mudu P; Leoncini L; Syrjänen K
Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women.
Cytopathology : official journal of the British Society for Clinical Cytology 2001;12(2):84-93.
2001: Costa S; Terzano P; Bovicelli A; Martoni A; Angelelli B; Santini D; Ceccarelli C; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Gynecologic oncology 2001;80(1):67-73.
2000: Tripodi S; Chang F; Syrjänen S; Shen Q; Cintorino M; Alia L; Santopietro R; Tosi P; Syrjänen K
Quantitative image analysis of oesophageal squamous cell carcinoma from the high-incidence area of China, with special reference to tumour progression and papillomavirus (HPV) involvement.
Anticancer research 2000;20(5C):3855-62.
2000: Anttila M A; Kellokoski J K; Moisio K I; Mitchell P J; Saarikoski S; Syrjänen K; Kosma V M
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer.
British journal of cancer 2000;82(12):1974-83.
2000: Costa S; Sideri M; Syrjänen K; Terzano P; De Nuzzo M; De Simone P; Cristiani P; Finarelli A C; Bovicelli A; Zamparelli A; Bovicelli L
Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
Acta cytologica 2000;44(3):310-8.
2000: Chang F; Syrjänen S; Shen Q; Cintorino M; Santopietro R; Tosi P; Syrjänen K
Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization.
Scandinavian journal of gastroenterology 2000;35(2):123-30.
1999: Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma V M
Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
British journal of cancer 1999;80(12):2001-7.
1999: Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu V K; Syrjänen S
Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Acta dermato-venereologica 1999;79(4):268-73.
1999: Anttila M A; Kosma V M; Hongxiu J; Puolakka J; Juhola M; Saarikoski S; Syrjänen K
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
British journal of cancer 1999;79(11-12):1870-8.
1999: Anttila M; Syrjänen S; Ji H; Saarikoski S; Syrjänen K
Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR.
Gynecologic oncology 1999;72(3):337-41.
1998: Syrjänen K
Anogenital human papilloma virus and the problem of persistence.
European journal of dermatology : EJD 1998;8(7 Suppl):5-7; discussion 20-2.
1998: Hietanen S; Auvinen E; Syrjänen K; Syrjänen S
Anti-proliferative effect of retinoids and interferon-alpha-2a on vaginal cell lines derived from squamous intra-epithelial lesions.
International journal of cancer. Journal international du cancer 1998;78(3):338-45.
1998: Anttila M; Kosma V M; Ji H; Wei-Ling X; Puolakka J; Juhola M; Saarikoski S; Syrjänen K
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2591-600.
1998: Hietanen S; Syrjänen K; Syrjänen S
Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype.
British journal of cancer 1998;77(5):766-75.
1997: Hietanen S; Ekblad U; Pelliniemi T T; Syrjänen K; Helenius H; Syrjänen S
Type I diabetic pregnancy and subclinical human papillomavirus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(2):153-6.
1997: Chang F; Syrjänen S; Wang L; Shen Q; Syrjänen K
p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China.
Anticancer research 1997;17(1B):709-15.
1997: Suonio E; Lipponen P; Mäenpää J; Syrjänen K; Kangas L; Tuomisto L
Mitotic index in the subrenal capsule assay as an indicator of the chemosensitivity of ovarian cancer.
Cancer chemotherapy and pharmacology 1997;41(1):15-21.
1997: Aaltomaa S; Lipponen P; Vesalainen S; Ala-Opas M; Eskelinen M; Syrjänen K
Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer.
European urology 1997;32(4):410-5.
1997: Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K
Prognostic value of Ki-67 expression in renal cell carcinomas.
European urology 1997;31(3):350-5.
1997: Pirinen R; Lipponen P; Aaltomaa S; Syrjänen K
Prognostic value of epidermal growth factor expression in breast cancer.
Journal of cancer research and clinical oncology 1997;123(1):63-8.
1996: Lu S; Syrjänen K; Havu V K; Syrjänen S
Failure to demonstrate human papillomavirus (HPV) involvement in Bowen's disease of the skin.
Archives of dermatological research 1996;289(1):40-5.
1996: Lu S; Syrjänen K; Havu V K; Syrjänen S
Expression of PCNA is associated with the presence of HPV DNA in skin warts.
Archives of dermatological research 1996;289(1):35-9.
1996: Zhu Z; Parviainen M; Männistö S; Pietinen P; Eskelinen M; Syrjänen K; Uusitupa M
Vitamin E concentration in breast adipose tissue of breast cancer patients (Kuopio, Finland).
Cancer causes & control : CCC 1996;7(6):591-5.
1996: Lappalainen K; Pirilä L; Jääskeläinen I; Syrjänen K; Syrjänen S
Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
Anticancer research 1996;16(5A):2485-92.
1996: Ji H; Yliskoski M; Anttila M; Syrjänen K; Saarikoski S
Management of stage-I borderline ovarian tumors.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1996;54(1):37-44.
1996: Lipponen P; Vesalainen S; Kasurinen J; Ala-Opas M; Syrjänen K
A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour.
Anticancer research 1996;16(4A):2095-100.
1996: Kurvinen K; Syrjänen K; Syrjänen S
p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(7):2120-30.
1996: Syrjänen K; Nurmi T; Mäntyjärvi R; Ilonen J; Syrjänen S; Surcel H M; Yliskoski M; Väyrynen M; Chang F; Saarikoski S
HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years.
Cytopathology : official journal of the British Society for Clinical Cytology 1996;7(2):99-107.
1996: Puranen M; Yliskoski M; Saarikoski S; Syrjänen K; Syrjänen S
Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood.
American journal of obstetrics and gynecology 1996;174(2):694-9.
1996: Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Syrjänen K
The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer.
Journal of cancer research and clinical oncology 1996;122(11):687-92.
1996: Puranen M; Syrjänen K; Syrjänen S
Transmission of genital human papillomavirus infections is unlikely through the floor and seats of humid dwellings in countries of high-level hygiene.
Scandinavian journal of infectious diseases 1996;28(3):243-6.
1995: Pirinen R; Lipponen P; Syrjänen K
Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.
Anticancer research 1995;15(6B):2835-40.
1995: Auvinen P; Lipponen P; Johansson R; Syrjänen K
Prognostic significance of TGF-beta 1 and TGF-beta 2 expressions in female breast cancer.
Anticancer research 1995;15(6B):2627-31.
1995: Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Syrjänen K
Expression of p53 protein has no independent prognostic value in breast cancer.
The Journal of pathology 1995;177(3):225-32.
1995: Hietanen S H; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
American journal of obstetrics and gynecology 1995;173(5):1477-82.
1995: Lipponen P; Pietiläinen T; Kosma V M; Aaltomaa S; Eskelinen M; Syrjänen K
Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis.
The Journal of pathology 1995;177(1):49-55.
1995: Vesalainen S; Lipponen P; Talja M; Kasurinen J; Syrjänen K
Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas.
The Prostate 1995;27(2):110-7.
1995: Zhu Z R; Parviainen M; Männistö S; Pietinen P; Eskelinen M; Syrjänen K; Uusitupa M
Vitamin A concentration in breast adipose tissue of breast cancer patients.
Anticancer research 1995;15(4):1593-6.
1995: Hietanen S; Grénman S; Syrjänen K; Lappalainen K; Kauppinen J; Carey T; Syrjänen S
Human papillomavirus in vulvar and vaginal carcinoma cell lines.
British journal of cancer 1995;72(1):134-9.
1995: Kärjä V; Syrjänen K; Syrjänen S
Collagen IV and tenascin immunoreactivity as prognostic determinant in benign and malignant salivary gland tumours.
Acta oto-laryngologica 1995;115(4):569-75.
1995: Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Syrjänen K
Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival.
Anticancer research 1995;15(3):959-64.
1995: Aaltonen M; Lipponen P; Kosma V M; Aaltomaa S; Syrjänen K
Prognostic value of cathepsin-D expression in female breast cancer.
Anticancer research 1995;15(3):1033-7.
1995: Lipponen P; Eskelinen M; Syrjänen K
Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.
British journal of cancer 1995;71(4):863-7.
1995: Chang F; Syrjänen S; Syrjänen K
Implications of the p53 tumor-suppressor gene in clinical oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):1009-22.
1995: Costa S; Syrjänen S; Vendra C; Chang F; Guida G; Hippeläinen M; Terzano P; Tervahauta A; Yliskoski M; Syrjänen K
Human papillomavirus infections in vulvar precancerous lesions and cancer.
The Journal of reproductive medicine 1995;40(4):291-8.
1995: Vesalainen S; Lipponen P; Nordling S; Talja M; Syrjänen K
Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology.
Anticancer research 1995;15(2):569-73.
1995: Vesalainen S; Lipponen P; Talja M; Syrjänen K
Mitotic activity and prognosis in prostatic adenocarcinoma.
The Prostate 1995;26(2):80-6.
1995: Kurvinen K; Hietanen S; Syrjänen K; Syrjänen S
Rapid and effective detection of mutations in the p53 gene using nonradioactive single-strand conformation polymorphism (SSCP) technique applied on PhastSystem.
Journal of virological methods 1995;51(1):43-53.
1995: Zhu Z R; Agren J; Männistö S; Pietinen P; Eskelinen M; Syrjänen K; Uusitupa M
Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease.
Nutrition and cancer 1995;24(2):151-60.
1995: Lu S; Syrjänen K; Havu V K; Syrjänen
No evidence of human papillomavirus DNA in actinic keratosis.
Archives of dermatological research 1995;287(7):649-51.
1995: Vesalainen S; Lipponen P; Talja M; Syrjänen K
Biochemical parameters as prognostic factors in prostatic adenocarcinoma.
Acta oncologica (Stockholm, Sweden) 1995;34(1):53-9.
1995: Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Syrjänen K
Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival.
European journal of cancer (Oxford, England : 1990) 1995;31A(3):329-33.
1995: Toropainen E; Lipponen P; Syrjänen K
Expression of insulin-like growth factor I (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosis.
European journal of cancer (Oxford, England : 1990) 1995;31A(9):1443-8.
1994: Lappalainen K; Urtti A; Söderling E; Jääskeläinen I; Syrjänen K; Syrjänen S
Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells.
Biochimica et biophysica acta 1994;1196(2):201-8.
1994: Chang F; Lipponen P; Tervahauta A; Syrjänen S; Syrjänen K
Transitional cell carcinoma of the bladder: failure to demonstrate human papillomavirus deoxyribonucleic acid by in situ hybridization and polymerase chain reaction.
The Journal of urology 1994;152(5 Pt 1):1429-33.
1994: Lipponen P; Saarelainen E; Ji H; Aaltomaa S; Syrjänen K
Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer.
The Journal of pathology 1994;174(2):101-9.
1994: Tervahauta A; Syrjänen S; Yliskoski M; Gold L I; Syrjänen K
Expression of transforming growth factor-beta 1 and -beta 2 in human papillomavirus (HPV)-associated lesions of the uterine cervix.
Gynecologic oncology 1994;54(3):349-56.
1994: Hippeläinen M I; Hippeläinen M; Saarikoski S; Syrjänen K
Clinical course and prognostic factors of human papillomavirus infections in men.
Sexually transmitted diseases 1994;21(5):272-9.
1994: Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
British journal of cancer 1994;70(2):346-51.
1994: Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
British journal of cancer 1994;70(2):309-14.
1994: Heinonen O; Soininen H; Syrjänen S; Neittaanmäki H; Paljärvi L; Kosunen O; Syrjänen K; Riekkinen P
beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study.
Archives of neurology 1994;51(8):799-804.
1994: Lappalainen K; Jääskeläinen I; Syrjänen K; Urtti A; Syrjänen S
Comparison of cell proliferation and toxicity assays using two cationic liposomes.
Pharmaceutical research 1994;11(8):1127-31.
1994: Tervahauta A; Syrjänen S; Syrjänen K
Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1994;13(3):234-40.
1994: Kärjä V; Syrjänen S; Kataja V; Syrjänen K
c-erbB-2 oncogene expression in salivary gland tumours.
ORL; journal for oto-rhino-laryngology and its related specialties 1994;56(4):206-12.
1994: Lipponen P; Eskelinen M; Hietala K; Syrjänen K; Gambetta R A
Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma.
International journal of cancer. Journal international du cancer 1994;57(2):275-80.
1994: Hippeläinen M I; Yliskoski M; Syrjänen S; Saastamoinen J; Hippeläinen M; Saarikoski S; Syrjänen K
Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners.
Sexually transmitted diseases 1994;21(2):76-82.
1994: Vesalainen S; Lipponen P; Talja M; Alhava E; Syrjänen K
Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma.
Anticancer research 1994;14(2B):709-14.
1994: Lappalainen K; Urtti A; Jääskeläinen I; Syrjänen K; Syrjänen S
Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells.
Antiviral research 1994;23(2):119-30.
1994: Kurvinen K; Tervahauta A; Syrjänen S; Chang F; Syrjänen K
The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing.
Anticancer research 1994;14(1A):177-81.
1994: Lipponen P; Ji H; Aaltomaa S; Syrjänen K
Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis.
Journal of cancer research and clinical oncology 1994;120(11):645-50.
1994: Vesalainen S; Lipponen P; Talja M; Syrjänen K
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma.
European journal of cancer (Oxford, England : 1990) 1994;30A(12):1797-803.
1994: Lipponen P; Aaltomaa S; Kosma V M; Syrjänen K
Apoptosis in breast cancer as related to histopathological characteristics and prognosis.
European journal of cancer (Oxford, England : 1990) 1994;30A(14):2068-73.
1993: Chang F; Syrjänen S; Shen Q; Wang L; Syrjänen K
Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization.
Cancer 1993;72(9):2525-30.
1993: Lipponen P; Aaltomaa S; Papinaho S; Syrjänen K
Nucleolar organizer regions in myofibroblasts in breast cancer. Relation to cancer cell morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis.
Pathology, research and practice 1993;189(9):1030-5.
1993: Kataja V; Syrjänen S; Yliskoski M; Hippelïnen M; Väyrynen M; Saarikoski S; Mäntyjärvi R; Jokela V; Salonen J T; Syrjänen K
Risk factors associated with cervical human papillomavirus infections: a case-control study.
American journal of epidemiology 1993;138(9):735-45.
1993: Hippeläinen M; Syrjänen S; Hippeläinen M; Koskela H; Pulkkinen J; Saarikoski S; Syrjänen K
Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts.
Sexually transmitted diseases 1993;20(6):321-8.
1993: Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K
The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
International journal of cancer. Journal international du cancer 1993;55(4):547-54.
1993: Chang F; Syrjänen S; Tervahauta A; Syrjänen K
Tumourigenesis associated with the p53 tumour suppressor gene.
British journal of cancer 1993;68(4):653-61.
1993: Lipponen P; Aaltomaa S; Syrjänen K
Morphometric quantitation of nucleolar organizer region proteins in breast carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1993;15(5):311-6.
1993: Hippeläinen M I; Syrjänen S; Hippeläinen M J; Saarikoski S; Syrjänen K
Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation.
Genitourinary medicine 1993;69(5):346-51.
1993: Lipponen P; Ji H; Aaltomaa S; Syrjänen S; Syrjänen K
p53 protein expression in breast cancer as related to histopathological characteristics and prognosis.
International journal of cancer. Journal international du cancer 1993;55(1):51-6.
1993: Lipponen H J; Aaltomaa S; Syrjänen S; Syrjänen K
c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Anticancer research 1993;13(4):1147-52.
1993: Hippeläinen M; Eskelinen M; Lipponen P; Chang F; Syrjänen K
Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus.
Anticancer research 1993;13(3):677-81.
1993: Aaltomaa S; Lipponen P; Syrjänen K
Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer.
Pathology, research and practice 1993;189(4):416-21.
1993: Aaltomaa S; Lipponen P; Syrjänen K
Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer.
Anticancer research 1993;13(2):533-8.
1993: Chang F; Syrjänen S; Kurvinen K; Syrjänen K
The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
The American journal of gastroenterology 1993;88(2):174-86.
1993: Heinonen O; Syrjänen S; Soininen H; Talasniemi S; Kaski M; Mäntyjärvi R; Syrjänen K; Riekkinen P
Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.
Neuroscience letters 1993;149(1):67-70.
1993: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Predictive value of a morphometric prognostic index in female breast cancer.
Oncology 1993;50(1):57-62.
1993: Aaltomaa S; Lipponen P; Papinaho S; Syrjänen K
Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
Journal of cancer research and clinical oncology 1993;119(5):288-94.
1992: Eskelinen M; Hippeläinen M; Salmela E; Paajanen H; Alhava E; Syrjänen K
A prospective study of tissue polypeptide specific antigen (TPS) in breast cancer diagnosis.
Anticancer research 1992;12(6B):2033-6.
1992: Tosi P; Cintorino M; Santopietro R; Lio R; Barbini P; Ji H; Chang F; Kataja V; Syrjänen S; Syrjänen K
Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV). Quantitative data and cytokeratin expression.
Pathology, research and practice 1992;188(7):866-73.
1992: Eskelinen M; Lipponen P; Syrjänen K
Nucleolar organiser regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma.
Anticancer research 1992;12(5):1635-40.
1992: Lipponen P; Papinaho S; Eskelinen M; Klemi P J; Aaltomaa S; Kosma V M; Marin S; Syrjänen K
DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
Anticancer research 1992;12(5):1533-8.
1992: Costa S; Syrjänen S; Vendra C; Chang F; Guida G; Tervahauta A; Hippeläinen M; Syrjänen K
Detection of human papillomavirus infections in the male sexual partners of women attending an STD clinic in Bologna.
International journal of STD & AIDS 1992;3(5):338-46.
1992: Halmekytö M; Syrjänen K; Jänne J; Alhonen L
Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene.
Biochemical and biophysical research communications 1992;187(1):493-7.
1992: Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Marin S; Syrjänen K
The changing importance of prognostic factors in breast cancer during long-term follow-up.
International journal of cancer. Journal international du cancer 1992;51(5):698-702.
1992: Eskelinen M; Lipponen P; Aaltomaa S; Kosma V M; Syrjänen K; Alhava E
Breast cancer in young women: clinical, histological and morphometric prognostic factors.
Anticancer research 1992;12(4):1237-42.
1992: Aaltomaa S; Lipponen P; Syrjänen K
Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
Anticancer research 1992;12(4):1281-6.
1992: Chang F; Syrjänen S; Shen Q; Wang L; Wang D; Syrjänen K
Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques.
Scandinavian journal of gastroenterology 1992;27(7):553-63.
1992: Eskelinen M; Lipponen P; Papinaho S; Aaltomaa S; Kosma V M; Klemi P; Syrjänen K
DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer.
International journal of cancer. Journal international du cancer 1992;51(4):555-61.
1992: Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
Scandinavian journal of dental research 1992;100(3):176-80.
1992: Lipponen P; Eskelinen M; Papinaho S; Klemi P J; Aaltomaa S; Kosma V M; Marin S; Syrjänen K
Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
Anticancer research 1992;12(3):677-82.
1992: Kataja V; Syrjänen S; Mäntyjärvi R; Yliskoski M; Saarikoski S; Syrjänen K
Prognostic factors in cervical human papillomavirus infections.
Sexually transmitted diseases 1992;19(3):154-60.
1992: Syrjänen S; Andersson B; Juntunen L; Syrjänen K
Polymerase chain reaction for producing biotinylated human papillomavirus DNA probes for in situ hybridization.
Sexually transmitted diseases 1992;19(3):140-5.
1992: Yliskoski M; Tervahauta A; Saarikoski S; Mäntyjärvi R; Syrjänen K
Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections.
Sexually transmitted diseases 1992;19(3):137-9.
1992: Syrjänen K; Kataja V; Yliskoski M; Chang F; Syrjänen S; Saarikoski S
Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System.
Obstetrics and gynecology 1992;79(5 ( Pt 1)):675-82.
1992: Tuppurainen K; Raninen A; Kosunen O; Kankkunen J P; Kellokoski J; Syrjänen S; Mäntyjärvi M; Syrjänen K
Squamous cell carcinoma of the conjunctiva. Failure to demonstrate HPV DNA by in situ hybridization and polymerase chain reaction.
Acta ophthalmologica 1992;70(2):248-54.
1992: Heinonen O; Syrjänen S; Mäntyjärvi R; Syrjänen K; Riekkinen P
JC virus infection and Alzheimer's disease: reappraisal of an in situ hybridization approach.
Annals of neurology 1992;31(4):439-41.
1992: Aaltomaa S; Lipponen P; Papinaho S; Klemi P; Kosma V M; Marin S; Eskelinen M; Alhava E; Syrjänen K
Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer.
The European journal of surgery = Acta chirurgica 1992;158(3):135-41.
1992: Kellokoski J; Syrjänen S; Yliskoski M; Syrjänen K
Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections.
Oral microbiology and immunology 1992;7(1):19-23.
1992: Eskelinen M; Lipponen P; Syrjänen K
Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival.
Anticancer research 1992;12(1):91-5.
1992: Soininen H; Syrjänen S; Heinonen O; Neittaanmäki H; Miettinen R; Paljärvi L; Syrjänen K; Beyreuther K; Riekkinen P
Amyloid beta-protein deposition in skin of patients with dementia.
Lancet 1992;339(8787):245.
1992: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1992;24(3):160-8.
1991: Ji H X; Yliskoski M; Väyrynen M; Hippeläinen M; Syrjänen S; Syrjänen K
Colposcopic analysis of genital human papillomavirus infections during an 8-year prospective follow-up.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1991;36(4):291-300.
1991: Kallio P; Syrjänen S; Tervahauta A; Syrjänen K
A simple method for isolation of DNA from formalin-fixed paraffin-embedded samples for PCR.
Journal of virological methods 1991;35(1):39-47.
1991: Halmekytö M; Hyttinen J M; Sinervirta R; Utriainen M; Myöhänen S; Voipio H M; Wahlfors J; Syrjänen S; Syrjänen K; Alhonen L
Transgenic mice aberrantly expressing human ornithine decarboxylase gene.
The Journal of biological chemistry 1991;266(29):19746-51.
1991: Yliskoski M; Syrjänen K; Syrjänen S; Saarikoski S; Nethersell A
Systemic alpha-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: double-blind, placebo-controlled trial.
Gynecologic oncology 1991;43(1):55-60.
1991: Eskelinen M; Lipponen P; Syrjänen K
TAG 12 expression as a prognostic factor in female breast cancer.
Anticancer research 1991;11(5):1683-6.
1991: Syrjänen S; Heinonen O; Miettinen R; Paljärvi L; Syrjänen K; Riekkinen P
Short biotinylated oligonucleotides bind non-specifically to senile plaques of Alzheimer's disease.
Neuroscience letters 1991;130(1):89-91.
1991: Tervahauta A; Eskelinen M; Syrjänen S; Lipponen P; Pajarinen P; Syrjänen K
Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
Anticancer research 1991;11(5):1677-81.
1991: Hippeläinen M; Yliskoski M; Saarikoski S; Syrjänen S; Syrjänen K
Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy.
Genitourinary medicine 1991;67(4):291-6.
1991: Chang F; Syrjänen S; Kellokoski J; Syrjänen K
Human papillomavirus (HPV) infections and their associations with oral disease.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1991;20(7):305-17.
1991: Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
The European journal of surgery = Acta chirurgica 1991;157(5):319-24.
1991: Chang F; Janatuinen E; Pikkarainen P; Syrjänen S; Syrjänen K
Esophageal squamous cell papillomas. Failure to detect human papillomavirus DNA by in situ hybridization and polymerase chain reaction.
Scandinavian journal of gastroenterology 1991;26(5):535-43.
1991: Syrjänen S; Andersson B; Juntunen L; Syrjänen K
The use of polymerase chain reaction in generation of biotinylated human papillomavirus DNA probes for in situ hybridization.
Journal of virological methods 1991;31(2-3):147-59.
1991: Kellokoski J; Syrjänen S; Tosi P; Cintorino M; Leoncini P; Syrjänen K
Cytokeratin pattern in normal and HPV infected oral mucosa in women with genital HPV infections.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1991;20(1):26-31.
1991: Eskelinen M; Lipponen P; Majapuro R; Syrjänen K
Prognostic factors in prostatic adenocarcinoma assessed by means of quantitative histology.
European urology 1991;19(4):274-8.
1991: Yliskoski M; Saarikoski S; Syrjänen K
Conization for CIN associated with human papillomavirus infection.
Archives of gynecology and obstetrics 1991;249(2):59-65.
1991: Lipponen P; Eskelinen M; Syrjänen S; Tervahauta A; Syrjänen K
Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder.
European urology 1991;20(3):238-42.
1990: Syrjänen K; Yliskoski M; Kataja V; Hippeläinen M; Syrjänen S; Saarikoski S; Ryhänen A
Prevalence of genital human papillomavirus infections in a mass-screened Finnish female population aged 20-65 years.
International journal of STD & AIDS 1990;1(6):410-5.
1990: Chang F; Kosunen O; Kosma V M; Syrjänen S; Lahtinen J; Syrjänen K
Verrucous carcinoma of the anus containing human papillomavirus type 16 DNA detected by in situ hybridisation: a case report.
Genitourinary medicine 1990;66(5):342-5.
1990: Laatikainen A; Sarkkinen H; Syrjänen K; Mäntyjärvi R
Local immune reaction in syngeneic mice against tumorigenic and nontumorigenic BPV-transformed mouse cell lines.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1990;98(10):909-15.
1990: Syrjänen S; Saastamoinen J; Chang F J; Ji H X; Syrjänen K
Colposcopy, punch biopsy, in situ DNA hybridization, and the polymerase chain reaction in searching for genital human papillomavirus (HPV) infections in women with normal PAP smears.
Journal of medical virology 1990;31(4):259-66.
1990: Kellokoski J; Syrjänen S; Kataja V; Yliskoski M; Syrjänen K
Acetowhite staining and its significance in diagnosis of oral mucosal lesions in women with genital HPV infections.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1990;19(6):278-83.
1990: Chang F; Shen Q; Zhou J; Wang C; Wang D; Syrjänen S; Syrjänen K
Detection of human papillomavirus DNA in cytologic specimens derived from esophageal precancer lesions and cancer.
Scandinavian journal of gastroenterology 1990;25(4):383-8.
1990: Kataja V; Syrjänen K; Syrjänen S; Mäntyjärvi R; Yliskoski M; Saarikoski S; Salonen J T
Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data.
European journal of epidemiology 1990;6(1):9-14.
1990: Yliskoski M; Cantell K; Syrjänen K; Syrjänen S
Topical treatment with human leukocyte interferon of HPV 16 infections associated with cervical and vaginal intraepithelial neoplasias.
Gynecologic oncology 1990;36(3):353-7.
1990: Kellokoski J; Syrjänen S; Syrjänen K; Yliskoski M
Oral mucosal changes in women with genital HPV infection.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1990;19(3):142-8.
1990: Syrjänen K; Hakama M; Saarikoski S; Väyrynen M; Yliskoski M; Syrjänen S; Kataja V; Castrén O
Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population.
Sexually transmitted diseases 1990;17(1):15-9.
1990: Chang F; Syrjänen S; Shen Q; Ji H X; Syrjänen K
Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China.
International journal of cancer. Journal international du cancer 1990;45(1):21-5.
1990: Syrjänen K; Syrjänen S
Epidemiology of human papilloma virus infections and genital neoplasia.
Scandinavian journal of infectious diseases. Supplementum 1990;69():7-17.
1990: Syrjänen S; Kärjä V; Chang F J; Johansson B; Syrjänen K
Epstein-Barr virus involvement in salivary gland lesions associated with Sjögren's syndrome.
ORL; journal for oto-rhino-laryngology and its related specialties 1990;52(4):254-9.
1990: Ji H X; Syrjänen S; Syrjänen K; Wu A R; Chang F J
In situ hybridization analysis of HPV DNA in cervical precancer and cervical cancers from China.
Archives of gynecology and obstetrics 1990;247(1):21-9.
1990: Laatikainen A; Karjalainen H; Sarkkinen H; Syrjänen K; Mäntyjärvi R
Generation of cell-mediated cytotoxicity against bovine-papilloma-virus-transformed primary mouse cell lines.
Cancer immunology, immunotherapy : CII 1990;30(6):351-6.
1990: Chang F; Syrjänen S; Shen Q; Ji H; Syrjänen K
Detection of human papillomavirus (HPV) in genital warts and carcinomas by DNA in situ hybridization in Chinese patients.
Cytopathology : official journal of the British Society for Clinical Cytology 1990;1(2):97-103.
1990: Chang F; Syrjänen S; Nuutinen J; Kärjä J; Syrjänen K
Detection of human papillomavirus (HPV) DNA in oral squamous cell carcinomas by in situ hybridization and polymerase chain reaction.
Archives of dermatological research 1990;282(8):493-7.
1990: Leoncini P; Petracca R; Ruggiero P; Cintorino M; Syrjänen S; Mäntyjärvi R; Syrjänen K
Expression of cytokeratin No. 19 polypeptide in genital papillomavirus lesions.
Gynecologic and obstetric investigation 1990;29(1):59-66.
1989: Mäntyjärvi M; Syrjänen S; Kaipiainen S; Mäntyjärvi R; Kahlos T; Syrjänen K
Detection of human papillomavirus type 11 DNA in a conjunctival squamous cell papilloma by in situ hybridization with biotinylated probes.
Acta ophthalmologica 1989;67(4):425-9.
1989: Syrjänen S; von Krogh G; Kellokoski J; Syrjänen K
Two different human papillomavirus (HPV) types associated with oral mucosal lesions in an HIV-seropositive man.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1989;18(6):366-70.
1989: Klemi P J; Joensuu H; Siivonen L; Virolainen E; Syrjänen S; Syrjänen K
Association of DNA aneuploidy with human papillomavirus-induced malignant transformation of sinonasal transitional papillomas.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1989;100(6):563-7.
1989: Parkkinen S; Mäntyjärvi R; Syrjänen K; Syvänen A C; Ranki M
Sandwich hybridization in solution: a rapid method to screen HPV 16 DNA in cervical scrapes.
Molecular and cellular probes 1989;3(1):1-11.
1989: Kataja V; Syrjänen K; Mäntyjärvi R; Väyrynen M; Syrjänen S; Saarikoski S; Parkkinen S; Yliskoski M; Salonen J T; Castren O
Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data.
European journal of epidemiology 1989;5(1):1-7.
1989: Yliskoski M; Saarikoski S; Syrjänen K; Syrjänen S; Castrén O
Cryotherapy and CO2-laser vaporization in the treatment of cervical and vaginal human papillomavirus (HPV) infections.
Acta obstetricia et gynecologica Scandinavica 1989;68(7):619-25.
1989: Syrjänen K; Syrjänen S
Concept of the existence of human papillomavirus (HPV) DNA in histologically normal squamous epithelium of the genital tract should be re-evaluated.
Acta obstetricia et gynecologica Scandinavica 1989;68(7):613-7.
1989: Syrjänen K; Syrjänen S; Kellokoski J; Kärjä J; Mäntyjärvi R
Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinomas demonstrated by in situ DNA hybridization.
Lung 1989;167(1):33-42.
1988: Syrjänen K; Mäntyjärvi R; Saarikoski S; Väyrynen M; Syrjänen S; Parkkinen S; Yliskoski M; Saastamoinen J; Castren O
Factors associated with progression of cervical human papillomavirus (HPV) infections into carcinoma in situ during a long-term prospective follow-up.
British journal of obstetrics and gynaecology 1988;95(11):1096-102.
1988: Parkkinen S; Syrjänen S; Syrjänen K; Yliskoski M; Tenhunen J; Mäntyjärvi R; Ranki M
Screening of premalignant cervical lesions for HPV 16 DNA by sandwich and in situ hybridization techniques.
Gynecologic oncology 1988;30(2):251-64.
1988: Syrjänen S; Partanen P; Mäntyjärvi R; Syrjänen K
Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes.
Journal of virological methods 1988;19(3-4):225-38.
1988: Mäntyjärvi R; Sarkkinen H; Parkkinen S; Laatikainen A; Ryhänen A; Syrjänen K
Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.
Intervirology 1988;29(6):311-9.
1988: Sorvari T; Sarnesto A; Syrjänen K
Type IV collagen in the basal membrane of human papillomavirus associated premalignant and malignant squamous cell lesions of the uterine cervix.
Gynecologic and obstetric investigation 1988;26(4):324-31.
1988: Mäntyjärvi R A; Sarkkinen H; Karajalainen H; Parkkinen S; Ryhänen A; Syrjänen K; Jägerroos H; Nurmi T
Tumour-associated antigens in primary mouse fibroblasts induced by transformation with bovine papillomavirus type 1.
Experimental pathology 1988;35(1):25-33.
1988: Tosi P; Luzi P; Santopietro R; Miracco C; Lio R; Syrjänen S; Mäntyjärvi R; Syrjänen K
Morphometric assessment of the biological potential of human papillomavirus infections in the uterine cervix.
Applied pathology 1988;6(4):247-57.
1988: Mäntyjärvi R; Sarkkinen H; Parkkinen S; Ryhänen A; Karjalainen H; Syrjänen K; Syrjänen S
Phenotypic transformation of primary mouse fibroblasts by BPV 1 DNA.
Archives of virology 1988;100(1-2):17-25.
1988: Cintorino M; Syrjänen S; Leoncini P; Bellizzi De Marco E; Petracca R; Pallini V; Tosi P; Mäntyjärvi R; Syrjänen K
Altered expression of filaggrin in human papillomavirus (HPV) lesions of the uterine cervix.
Archives of gynecology and obstetrics 1988;241(4):235-47.
1987: Syrjänen S; Happonen R P; Virolainen E; Siivonen L; Syrjänen K
Detection of human papillomavirus (HPV) structural antigens and DNA types in inverted papillomas and squamous cell carcinomas of the nasal cavities and paranasal sinuses.
Acta oto-laryngologica 1987;104(3-4):334-41.
1987: Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
Archiv für Geschwulstforschung 1987;57(4):265-74.
1987: Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity.
Neoplasma 1987;34(4):431-9.
1987: Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. III. Morphometric assessment of the dynamic changes in post-capillary venules as regulatory elements of lymphocyte recirculation in tumor-draining lymph nodes.
Archiv für Geschwulstforschung 1987;57(1):7-15.
1986: Syrjänen K; Tosi P; Cintorino M; Mäntyjärvi R; Luzi P; Leoncini L; Laatikainen A; Miracco C; Santopietro R
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. II. Morphometric assessment of immunoreactivity in the thymus and spleen related to lymphocyte subsets in peripheral blood.
Experimental pathology 1986;30(2):75-82.
1986: Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R
Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. I. Morphometric assessment of lymph node immunoreactivity and analysis of circulating antibodies.
Experimental pathology 1986;30(2):65-74.
1986: Syrjänen K; Väyrynen M; Mäntyjärvi R; Castren O; Saarikoski S
Natural killer (NK) cells with HNK-1 phenotype in the cervical biopsies of women followed-up for human papillomavirus (HPV) lesions.
Acta obstetricia et gynecologica Scandinavica 1986;65(2):139-45.
1985: Syrjänen K; Väyrynen M; Saarikoski S; Mäntyjärvi R; Parkkinen S; Hippeläinen M; Castren O
Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up.
British journal of obstetrics and gynaecology 1985;92(11):1086-92.
1985: Syrjänen K; de Villiers E M; Saarikoski S; Castren O; Väyrynen M; Mäntyjärvi R; Parkkinen S
Cervical papillomavirus infection progressing to invasive cancer in less than three years.
Lancet 1985;1(8427):510-1.
1985: Syrjänen K; Väyrynen M; Hippeläinen M; Castrén O; Saarikoski S; Mäntyjärvi R
Electron microscopic assessment of cervical punch biopsies in women followed-up for human papillomavirus (HPV) lesions.
Archiv für Geschwulstforschung 1985;55(2):131-8.
1981: Väyrynen M; Romppanen T; Koskela E; Castren O; Syrjänen K
Verrucous squamous cell carcinoma of the female genital tract. Report of three cases and survey of the literature.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1981;19(5):351-6.

Sign-in to see more